TLRY
Recent Headlines
- Why Tilray and Other Pot Stocks Jumped Today
- Crain Communications Enters Cannabis WIth Acquisition of Green Market Report
- Canadian retail cannabis sales set record, shares rise
- Tilray to Announce First Quarter Fiscal 2022 Financial Results on October 7, 2021
- 3 Hot Cannabis Stocks That Should be on Your Watchlist
- 3 Things About Tilray That Smart Investors Know
- House includes cannabis banking measure in National Defense Authorization Act
- Why Aurora Cannabis, Canopy Growth, and Tilray Stock Tumbled Today
- Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know
- ROSE LifeScience Announces Expanded Distribution Partnership with Tilray Canada
- Tilray, Inc. (TLRY) Dips More Than Broader Markets: What You Should Know
- Cannabis Sector Weekly Roundup
- The Week In Cannabis: Tilray, BMW, Teen Use, The Valens Co, Flora Growth, Italy And More
- Tilray Stockholders Approve Increase In Number Of Shares To Help Drive $4B In Revenue, Stock Trades Down
- Tilray Stockholders Approve Proposal to Increase Authorized Shares at Special Meeting
- 2 Market-Crushing Stocks That Analysts Think Can Still Soar Higher
- Which Canadian Cannabis Company Is In the Best Position to Enter the U.S. Market?
- Tilray to Participate in Barclays Global Consumer Staples Conference on September 10th, 2021
- 2 Robinhood Stocks With Market-Beating Potential
- Why Tilray, Canopy Growth, and Hexo Stock Rose Today
- Why Aurora Cannabis, Tilray, and Sundial Growers Stocks Are Smoking Today
- The Week In Cannabis: $1.25B+ In Financings And M&A, Tilray, KushCo, New York And More
- Tilray Chairman and CEO, Irwin D. Simon, Sends Shareholder Letter Mapping out $4B Revenue Plan
- Estimating the Intrinsic Value of Tilray, Inc. (NASDAQ:TLRY)
- Tilray: Is MedMen the Right Fit? Analyst Weighs In
- Tilray Has Found a Partner for Its Expansion Into the U.S. Pot Market
- Bullish Tuesday For Marijuana Stocks - Sundial, Aurora, Tilray & Cronos Among Top Gainers
- Cross-Border Pot Deals Getting More Creative
- The Week In Cannabis: PharmaCann Could IPO, Tilray & MedMen, First Black CEO At Major Public Co. And More
- The Flowr Corporation Provides Operational Update
- Aurora, Sundial And Tilray Fall: A Look Into The Top Marijuana Stock Movers From Today
- Tilray's Relative Strength Moves Higher
- Why Aurora Cannabis, Tilray, and Sundial Growers Stocks Tumbled Today
- Tilray Adjourns Special Meeting Of Stockholders Until Sept. 10
- Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021
- Cannabis Stocks Are Lighting Up Investors Portfolios
- Why Tilray Stock Rose Today
- Why Tilray Bears Could Go Up In Smoke If History Repeats
- Tilray Found a Complicated Way to Enter the U.S. Marijuana Market. Why Its Stock Is Gaining.
- Why Sundial Growers Stock Popped Wednesday Morning
- Analysts upbeat on Tilray’s U.S. prospects after MedMen deal
- Tilray Eyes U.S. Marijuana Entry in MedMen Deal. What Wall Street Is Saying.
- Tilray Eyes Foothold In U.S. Marijuana Market With Debt Deal
- Why Tilray Shares Are Trading Higher Today
- Tilray Jumps, BlackBerry Gains — And What Else Is Happening in the Stock Market Wednesday
- Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?
- Cantor Fitzgerald Says Tilray's Stake In MedMen One Of The Steps In US Journey, Could Be Getting Close To Altria
- Is Tilray a Warren Buffett Stock?
- Is Tilray's Stock a Smart Buy After Its Q4 Earnings?
- Tilray Stock Rises as Analysts Support MedMen Deal